NCT02869321View on ClinicalTrials.gov

Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
GastrostomyBreakthrough PainUpper Aerodigestive Tract Neoplasms
Interventions
DRUG

Fentanyl

DRUG

Morphine Sulfate

DRUG

Fentanyl placebo

DRUG

Morphine Sulfate placebo

PROCEDURE

Gastrostomy

Trial Locations (1)

Unknown

Service ORL - CHU NANCY, Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT02869321 - Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy | Biotech Hunter | Biotech Hunter